Imsight Technology is training AI to analyze medical images for faster and more consistent disease detection using award winning deep-learning techniques. Imsight’s product portfolio tackles a wide variety of medical images from CT, MRI and X-ray to microscopic cell images in cytopathology and histopathology. The technology being developed will aid radiologist and pathologists alike to face mounting workloads, long report turnover times, and diagnostic inconsistencies. Imsight products are currently being used by over 30 top hospitals in China with over 100 ongoing research collaborations. Imsight is headquartered in Shenzhen with offices in Hong Kong, Beijing, Chengdu and Guiyang. For more information, please visit www.imsightmed.com